Related content

Selective cannabinoid receptor 2 modulators: a patent review 2009 – present

By Riether Doris  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 495-510

Informa Healthcare

Access to resources Recommend Favorite

Modulators of complement activation: a patent review (2008 – 2013)

By Larghi Enrique L   Kaufman Teodoro S  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 665-686

Informa Healthcare

Access to resources Recommend Favorite

mGluR2 positive allosteric modulators: a patent review (2009 – present)

By Trabanco Andrés A   Cid José María  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 629-647

Informa Healthcare

Access to resources Recommend Favorite

Acridine and its derivatives: a patent review (2009 – 2013)

By Zhang Bin   Li Xi   Li Bin   Gao Chunmei   Jiang Yuyang  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 647-664

Informa Healthcare

Access to resources Recommend Favorite

αα_2C-adrenoceptor modulators: a patent review

By Quaglia Wilma   Del Bello Fabio   Giannella Mario   Piergentili Alessandro   Pigini Maria  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 455-481

Informa Healthcare

Access to resources Recommend Favorite